相关实验视频
Updated: Jul 11, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
在精神分裂症患者中管理与抗精神病相关的性功能障碍
Carlos Silva1,2, Marta Rebelo1, Inês Chendo1,2,3
1Psychiatry Department, Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal.
Expert review of neurotherapeutics
|November 9, 2023
概括
性功能障碍在精神分裂症患者中很常见,通常治疗不足. 管理需要一个全面的方法,包括抗精神病调整,切换药物,或添加联合干预措施,以提高生活质量和坚持.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症是一种严重的精神疾病,性功能障碍的高率.
- 性功能障碍会对患者的生活质量和治疗坚持产生负面影响.
- 抗精神病药物往往与此有关,但负面症状也会有所影响.
研究的目的:
- 审查关于精神分裂症性功能障碍的当前知识.
- 探索抗精神病药物对性功能的机制和影响.
- 在这个人群中介绍性功能障碍的治疗策略.
主要方法:
- 对精神分裂症性功能障碍机制的文献综述.
- 对抗精神病对性功能影响的分析.
- 对药物和非药物治疗方案的评估.
主要成果:
- 性功能障碍在精神分裂症中普遍存在,诊断不足,治疗不足.
- 抗精神病药物是一个重要的因素,但负面症状也起作用.
- 有效的管理需要全面的方法.
结论:
- 临床医生必须积极评估和解决精神分裂症中的性功能障碍.
- 药理学策略包括剂量调整,切换抗精神病药物 (例如,对阿里皮普拉,布雷克斯皮普拉),或添加基化酶-5抑制剂.
- 药理学和非药理学方法的结合对于最佳结果至关重要.
相关概念视频
Psychosis and Antipsychotic Drugs: Overview
289
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
289
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47
Psychosis: Goals of Pharmacotherapy
143
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
143
Antipsychotic Drugs: Therapeutic Uses and Side Effects
229
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
229
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281

